Articles tagged with: Pharmaceuticals
Let’s make it right: A fit-for-purpose EU Paediatric Regulation can deliver for all children and adolescents with cancer Partner Content
01 Jul
Let’s make it right: A fit-for-purpose EU Paediatric Regulation can deliver for all children and adolescents with cancer
A political commitment to unleash the life-saving potential of the EU Pharmaceutical Strategy is needed say Gilles Vassal, Board Member of SIOP Europe, and Delphine Heenen, Committee Member of CCI Europe.
Making Europe a life sciences leader Partner Content
07 Jul
Making Europe a life sciences leader
EFPIA’s new board leadership team aims to combat COVID-19 and tackle societal challenges in order to make Europe a life sciences leader, writes Hubertus von Baumbach.
Rebuilding trust in science Partner Content
07 Jul
Rebuilding trust in science
The current pandemic has shown the importance of science; however, tackling future challenges requires a relationship based on trust between scientists and society, argues MEP Ivars Ijabs.
Health & Wellbeing: Securing the future for health
06 Jul
Health & Wellbeing: Securing the future for health
Now is the time to establish a new and better strategy for healthcare that future-proofs supplies of medicines and medical goods, writes Tomislav Sokol.
How do we solve the rare disease crisis? Partner Content
27 May
How do we solve the rare disease crisis?
Pfizer often made the headlines over the past year after mobilising their scientific expertise and manufacturing capabilities to respond to the COVID-19 pandemic. Reda Guiha, Regional President for Rare Disease at Pfizer, argues that the same sense of urgency and public-private sector collaboration that brought vaccines to patients within a year should be applied to other areas of critical unmet medical need, such as rare disease.
Rethinking obesity Partner Content
27 May
Rethinking obesity
There is a growing and urgent need for public health initiatives and objectives to meet the challenges of obesity. Jon Benton reports on a recent Herbalife Nutrition event that put treatment of the chronic disease under the microscope.
EU Member States to resume AstraZeneca COVID vaccinations
19 Mar
EU Member States to resume AstraZeneca COVID vaccinations
Move follows European Medicines Agency’s all clear regarding blood clot concerns.
MEPs call on pharma companies to increase COVID-19 vaccine production
26 Feb
MEPs call on pharma companies to increase COVID-19 vaccine production
European Parliament’s Socialist MEPs also want pharmaceutical giants to research against potential future Coronavirus variants and strains.
The pharmaceutical industry can be the catalyst for a sustainable and resilient healthcare system in Greece Partner Content
03 Feb
The pharmaceutical industry can be the catalyst for a sustainable and resilient healthcare system in Greece
SFEE and its member companies are committed to ensuring the sustainability of our healthcare systems by breaking barriers and silos and working together with policymakers to deliver outcomes to patients, society and the national economy, writes Olympios Papadimitriou.
MEPs in talks on holding public hearing with vaccine producers
27 Jan
MEPs in talks on holding public hearing with vaccine producers
Call from European Parliament’s Renew Europe Group follows concerns over vaccine availability and deployment.
Issue 523 | 26 October 2020
23 Oct
Issue 523 | 26 October 2020
Our cover star this issue is Swedish S&D deputy Jytte Guteland. As rapporteur of the European Climate Law, Guteland is keenly aware of the climate struggles facing our planet. She tells Lorna Hutchinson of her determination to build a more sustainable future.
European Parliament keen to play key role in boosting actions to tackle AMR
14 Jul
European Parliament keen to play key role in boosting actions to tackle AMR
COVID-19 may only be a foretaste of what we could expect from a world where antimicrobials are no longer effective, explains deputy chair of the European Parliament’s MEP interest group on AMR, Tiemo Wölken
New AMR Action Fund could be ‘game changer’ in battle against antimicrobial resistance
10 Jul
New AMR Action Fund could be ‘game changer’ in battle against antimicrobial resistance
Fund’s launch comes with warning that up to ten million lives could be lost globally each year by 2050 to antimicrobial resistant ‘superbugs’.
Why the EU needs pharmaceutical independence
10 Jul
Why the EU needs pharmaceutical independence
The Coronavirus outbreak has shown why the EU must address medical shortages and re-establish its position as a world leader in the pharmaceutical field, argues Tomislav Sokol.
EU Pharmaceutical Strategy could be a lost opportunity if action is not taken now Partner Content
02 Jul
EU Pharmaceutical Strategy could be a lost opportunity if action is not taken now
In its current form, the pharma strategy roadmap lacks the necessary drivers of innovation to put Europe back at the forefront of medical discovery, writes Nathalie Moll